UNSPSC 51434944: Hydrochlorothiazide/moexipril

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434944 Hydrochlorothiazide/moexipril is a Commodity code that captures state and local procurement of specific pharmaceutical products—in this case, a combination antihypertensive agent. Recent solicitations show state and local governments buying emergency medications, generic multi-source pharmaceuticals, and over-the-counter products through a mix of direct city procurement, state health agencies, and cooperative purchasing alliances. The City of Tampa Fire Rescue procures advanced life support medications including specific injectable agents (Labetalol, Epinephrine, Adenosine, Diltiazem) under firm-price contracts with nine-month expiration requirements and expedited delivery within ten days. The Texas Health and Human Services Commission is exploring direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager channels. State and local buyers emphasize cGMP and Drug Supply Chain Security Act compliance, OSHA Safety Data Sheet submission, FDA approval, and minimum shelf-life guarantees. Issuing bodies include municipal fire departments and emergency services, state health and human services commissions, and multistate cooperative purchasing alliances. Small local business enterprise set-asides appear in some procurements, with the Tampa solicitation offering a 5 percent SLBE bid discount.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, recently issued an RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, open to manufacturers supplying through AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson wholesalers across Minnesota and Oregon. The City of Tampa issued an IFB (Bid No. 26-P-00188) on April 24, 2026 for advanced life support medications with an April 8, 2026 deadline and an estimated contract value of $40,000.00. The Texas HHS Commission posted a Request for Information on April 3, 2026 regarding direct-to-manufacturer prescription programs, signaling early-stage exploration of supply-chain alternatives. Geographic activity spans Florida (Tampa), Texas, Minnesota, and Oregon through cooperative vehicles. Manufacturers supplying these codes face competitive pricing evaluation (often weighted 75 percent or more), multi-year contract terms (typically two years with renewal options), and requirements for comprehensive product data, EDI capability, and direct wholesaler relationships with chargeback systems in place.